Facilitated By

San Antonio Medical Foundation

News

  • KU professor's research proves some science textbooks wrong

    They wanted to share the research in Bioscience, because it's read by a broader variety of science-types, including high school science teachers.

  • Puma Biotech (PBYI) Announces Encouraging Interim Data from PB272 Phase 2 Control Trial in ...

    Puma Biotechnology, Inc. (NYSE: PBYI) announced that interim results from a Phase II clinical trial of Puma's investigational drug PB272 (neratinib) ...

  • Puma Biotech (PBYI) Updates on PB272 NSABP FB-7 Phase 2; No Significant Difference Noted

    Puma Biotechnology, Inc. (NYSE: PBYI) announced that a biomarker ... 2016 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) that is ...

  • Texas Innovations in Health Care: More Austin biotech companies go public, but hit stock turbulence

    Editor's Note: This article is part of a special series produced jointly by the Business Journals in Austin, Dallas, Houston and San Antonio, highlighting ...

  • This Booming Tea Seller Has 3 Business-Building Lessons to Share

    So he and his roommate, Rickey Ishida (who happened to be a biomedical engineer), began experimenting with high-caffeine tea blends to get ...